Amniotic Products Global Market Report 2024

Amniotic products encompass ortho-biologic solutions that leverage materials derived from amniotic sources, including amniotic membranes and fluid products, to promote healing and reduce inflammation in joints. The application of amniotic products at the site of injury facilitates tissue growth, contributing to the overall recovery process.

The primary categories of amniotic products include amniotic membranes and amniotic suspensions. Amniotic membranes consist of the innermost layer of the placenta, featuring a robust foundation membrane and an avascular stromal matrix. These membranes find applications in surgical dressing for burns, tissue restoration in oral and bladder procedures, as well as interventions such as tympanoplasty, arthroplasty, omphalocele repair, and prevention of adhesions in pelvic and abdominal surgeries. Amniotic products are utilized across medical specialties, including wound care, orthopedics, ophthalmology, and others, with their deployment occurring in hospitals, ambulatory surgical centers, and similar healthcare settings.

The amniotic products market research report is one of a series of new reports from The Business Research Company that provides amniotic products market statistics, including amniotic products industry global market size, regional shares, competitors with an amniotic products market share, detailed amniotic products market segments, market trends and opportunities, and any further data you may need to thrive in the amniotic products industry. This amniotic products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The amniotic products market size has grown strongly in recent years. It will grow from $0.9 billion in 2023 to $0.98 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The expansion observed in the historic period can be linked to a heightened incidence of burn injuries, a growing recognition of regenerative medicine, an increased utilization of amniotic products in surgical wound care, a rising awareness regarding the efficacy of amniotic products as a viable treatment option, and the global proliferation of amniotic products.

The amniotic products market size is expected to see strong growth in the next few years. It will grow to $1.37 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The anticipated growth in the forecast period can be associated with the growing preference among patients for non-invasive therapies, an increasing prevalence of chronic wounds, collaborative efforts and partnerships in the healthcare industry, the impact of the COVID-19 pandemic, a rise in the prevalence of ophthalmic disorders, and an overall increase in healthcare expenditure. Major trends expected in the forecast period include the continuous evolution of product technology, strong growth potential, regional dynamics, the lasting impact of COVID-19 and the potential effects of a global recession, an expansion in the target patient population, and emerging economies playing a significant role.

The surge in trauma and accident cases is anticipated to be a driving force behind the burgeoning growth of the amniotic products market. Trauma refers to abrupt and severe physical injuries necessitating urgent medical attention, while accidents encompass unintentional incidents such as slips, vehicular mishaps, or sports injuries. Notably, third-degree burn injuries often necessitate treatment involving full-thickness skin excision combined with a wound dressing composed of a hyper-dry human amniotic membrane. For instance, statistics from the Road Accidents in India 2021 report, published by the Ministry of Road Transport and Highways, an Indian government ministry, indicated a staggering 4,12,432 reported accidents in 2021. Moreover, a report from the National Highway Traffic Safety Administration, a US-based government agency, highlighted 42,915 fatalities resulting from motor vehicle traffic crashes in 2021. These escalating numbers underscore the pivotal role of amniotic products in addressing injuries stemming from trauma and accidents, hence fostering growth in the market.

The escalating demand for surgical interventions is poised to be a significant catalyst propelling the amniotic products market forward. Surgical procedures encompass a range of medical interventions conducted by qualified surgeons to remedy, reconstruct, extract, or substitute a part of the body affected by illness or injury. Amniotic products hold substantial value in surgical procedures, facilitating tissue regeneration, curbing inflammation at surgical sites, expediting recovery, minimizing postoperative discomfort, mitigating pain, and fortifying tissue repair and protection. Noteworthy statistics from the American Society for Metabolic and Bariatric Surgery (ASMBS) in June 2022 underscored that approximately 262,893 bariatric surgeries were performed in 2021. These figures highlight the amplified demand for surgical procedures, thereby fueling the escalating utilization and subsequent growth of amniotic products within the medical landscape.

Innovation stands as a central trend propelling advancements in the amniotic products market. Key industry players are focusing on developing pioneering products to fortify their standing within this competitive landscape. For example, Versea Health Inc., a US-based life science company, introduced Biovance 3L ocular tri-layer human amniotic membrane in November 2022. This product, available in sheet and disc forms, specifically targets surgical and ocular segments. Biovance 3L and Biovance 3L Ocular are tri-layer human amniotic membrane products designed to offer an extracellular matrix for biological membrane covering, fostering healing and tissue growth during wound recovery.

Major companies in the amniotic products market are directing their efforts towards innovative solutions such as dual-layer allografts to drive market growth and bolster revenues. Dual-layer allografts serve patients with complex surgical wounds, burns, and non-healing acute or chronic wounds. For instance, in February 2022, Amnio Technology LLC, a US-based company specializing in amnion-derived technologies, unveiled the palingen dual-layer membrane and dual-layer palingen X-membrane. These advanced allografts target challenging surgical wounds and leverage a dual-layered structure. The design utilizes two Advantek processes, ensuring unidirectional application while preserving the crucial regulatory proteins and extracellular matrix constituents inherent in amniotic tissue. The dual-layer construction and specialized Advantek processes in palingen membranes safeguard the regulatory proteins and extracellular matrix constituents, enhancing their effectiveness in addressing challenging wounds and facilitating tissue repair and regeneration.

In January 2021, Integra LifeSciences, a Canada-based precision medicine company, completed the acquisition of ACell Inc. for an undisclosed amount. This strategic move is part of Integra LifeSciences' initiative to broaden its portfolio of complex wound treatment solutions, leveraging ACell's proprietary MatriStem UBM technologies. ACell Inc., based in the United States, is a biotechnology firm specializing in providing acellular amniotic membrane products.

Major companies operating in the amniotic products market report are Stryker Corporation, Smith & Nephew PLC, Integra LifeSciences Holdings Corporation, Lucina BioSciences LLC, Bioventus LLC, Organogenesis Inc., Alphatec Spine Inc., MiMedx Group, HMP Global, AlloSource, Orthofix US LLC, ACell Inc., Aziyo Biologics Inc., TissueTech Inc., Amino Technology LLC, LifeCell International Pvt. Ltd., Tissue Regenix Group PLC, Aroa Biosurgery Limited, Skye Biologics Inc., Celularity Inc., Sanuwave Health Inc., NuVision Biotherapies Ltd., VIVEX Biologics Inc., Labtician Ophthalmics Inc., Genesis Biologics Inc., Applied Biologics LLC, Katena Products Inc., Next Biosciences, Surgenex LLC, Ventris Medical LLC

North America was the largest region in the amniotic products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the amniotic products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The amniotic products market consists of sales of amniotic tissue matrix and amniotic fluid cells. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Amniotic Products Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on amniotic products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for amniotic products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The amniotic products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Amniotic Membranes; Amniotic Suspensions
• 2) By Application: Wound Care; Orthopedics; Ophthalmology; Other Applications
• 3) By End-Use: Hospitals And Ambulatory Surgical Centers; Other End Users
• Companies Mentioned: Stryker Corporation; Smith & Nephew plc; Integra LifeSciences Holdings Corporation; Lucina BioSciences LLC; Bioventus LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.